Page last updated: 2024-09-03

y 27632 and ag-490

y 27632 has been researched along with ag-490 in 3 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(ag-490)
Trials
(ag-490)
Recent Studies (post-2010) (ag-490)
1,92438917322322

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)ag-490 (IC50)
Epidermal growth factor receptorHomo sapiens (human)1.9224
Tyrosine-protein kinase JAK1Homo sapiens (human)3.38
large T antigenBetapolyomavirus macacae14.61

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Bao, LY; Chen, K; Dai, ZT; Gu, CJ; Guo, W; Huang, F; Li, H; Li, HH; Li, JP; Liao, XH; Wang, J; Xiang, Y; Zhang, HM; Zhang, TC; Zhang, ZJ1

Other Studies

3 other study(ies) available for y 27632 and ag-490

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013
MKL-1 is a coactivator for STAT5b, the regulator of Treg cell development and function.
    Cell communication and signaling : CCS, 2020, 07-09, Volume: 18, Issue:1

    Topics: Amides; Base Sequence; Biomarkers; CD3 Complex; Cell Nucleus; Forkhead Transcription Factors; Humans; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Janus Kinase 3; Lymphocyte Count; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Protein Domains; Purpura, Thrombocytopenic, Idiopathic; Pyridines; rhoA GTP-Binding Protein; Serum Response Factor; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes, Regulatory; Trans-Activators; Tyrphostins

2020